{"auto_progress_calculation":false,"computation_units":"Percentage (%)","copyright":"","data_footnote":"","data_non_statistical":false,"data_notice_class":"","data_notice_heading":"","data_notice_text":"","data_show_map":true,"data_start_values":[{"field":"Antigen or vaccine","value":"Meningococcal type C"},{"field":"Antigen or vaccine","value":"Hepatitis B"},{"field":"Antigen or vaccine","value":"Polio"},{"field":"Antigen or vaccine","value":"Measles"},{"field":"Antigen or vaccine","value":"Varicella"},{"field":"Target population","value":"Recommended vaccines for 2-year-old children"},{"field":"Geography","value":"Canada"},{"field":"Gender","value":"Total - Gender"}],"embedded_feature_footer":"","embedded_feature_html":"","embedded_feature_tab_title":"","embedded_feature_title":"","embedded_feature_url":"","expected_disaggregations":["Geography"],"graph_annotations":[],"graph_limits":[],"graph_stacked_disaggregation":"","graph_title":"Vaccination rates for selected diseases","graph_titles":[],"graph_type":"line","indicator_name":"Proportion of the target population covered by all vaccines included in their national programme","indicator_number":"3.b.1","national_geographical_coverage":"Canada","page_content":"","permalink":"","precision":[],"progress_calculation_options":[{"direction":"positive","target":100,"disaggregation":[{"field":"Antigen or vaccine","value":"Diphtheria"},{"field":"Target population","value":"Recommended vaccines for 2-year-old children"},{"field":"Geography","value":"Canada"}]}],"progress_status":"not_available_manual","reporting_status":"complete","sort":"","standalone":false,"tags":[],"\u00ef\u00bb\u00bfcomposite_breakdown_label":"","SDG_GOAL":"<p>Goal 3: Ensure healthy lives and promote well-being for all at all ages</p>","SDG_TARGET":"<p>Target 3.b: Support the research and development of vaccines and medicines for the communicable and non&#x2011;communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all</p>","SDG_INDICATOR":"<p>Indicator 3.b.1: Proportion of the target population covered by all vaccines included in their national programme</p>","STAT_CONC_DEF":"This indicator measures the childhood vaccination rates for selected diseases. The Public Health Agency of Canada routinely monitors childhood vaccination coverage in Canada through the childhood National Immunization Coverage Survey.","DATA_COMP":"Data were readily available to report on this indicator as specified by the metadata. Please refer to the sources to access additional information on the metadata or source.","REC_USE_LIM":"The childhood vaccines included were those that are publicly funded under provincial/territorial programs. \n<br>\n<br>Vaccines recommended only for travel and some high-risk groups were excluded. \n<br>\n<br>The survey excluded First Nations on-reserve communities and institutionalized children.\n<br>\n<br> Gender disaggregation data is available only at Canada-level when selecting the following categories: \n\"Recommended vaccines for 14-year-old children,\" specifically for \"Hepatitis B\" or \"Human Papillomavirus (HPV)\".\n","PROGRESS_DETAILS":"   ","SDG_GOAL__GLOBAL":"<p>Goal 3: Ensure healthy lives and promote well-being for all at all ages</p>","SDG_TARGET__GLOBAL":"<p>Target 3.b: Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all</p>","SDG_INDICATOR__GLOBAL":"<p>Indicator 3.b.1: Proportion of the target population covered by all vaccines included in their national programme</p>","un_designated_tier":"Tier I","un_custodian_agency":"World Health Organization (WHO),  United Nations International Children's Emergency Fund (UNICEF)","goal_meta_link":"https://unstats.un.org/sdgs/metadata/files/Metadata-03-0b-01.pdf","goal_meta_link_text":"United Nations Sustainable Development Goals Metadata","source_active_1":true,"source_url_text_1":"Statistics Canada. Table 13-10-0870-01  Vaccine coverage estimates for recommended vaccines in children and pregnant women","source_url_1":"https://doi.org/10.25318/1310087001-eng","source_organisation_1":"Statistics Canada","source_periodicity_1":"Occasional","source_geographical_coverage_1":"Canada, provinces and territories","fr":{"SDG_GOAL":"<p>Objectif 3 : Permettre \u00e0 tous de vivre en bonne sant\u00e9 et promouvoir le bien-\u00eatre de tous \u00e0 tout \u00e2ge.</p>","SDG_TARGET":"<p>Cible 3.b : Appuyer la recherche et le d\u00e9veloppement de vaccins et de m\u00e9dicaments contre les maladies, transmissibles ou non, qui touchent principalement les habitants des pays en\u00a0d\u00e9veloppement, donner acc\u00e8s, \u00e0 un co\u00fbt abordable, aux\u00a0m\u00e9dicaments et vaccins essentiels, conform\u00e9ment \u00e0 la\u00a0D\u00e9claration de Doha sur l\u2019Accord sur les aspects des droits de propri\u00e9t\u00e9 intellectuelle qui touchent au commerce (ADPIC) et la sant\u00e9 publique, qui r\u00e9affirme le droit qu\u2019ont les pays en d\u00e9veloppement de tirer pleinement parti des dispositions de cet accord qui m\u00e9nagent une flexibilit\u00e9 lorsqu\u2019il s\u2019agit de prot\u00e9ger la sant\u00e9 publique et, en particulier, d\u2019assurer l\u2019acc\u00e8s universel aux m\u00e9dicaments</p>","SDG_INDICATOR":"<p>Indicateur 3.b.1 : Proportion de la population cible ayant re\u00e7u tous les vaccins pr\u00e9vus par le programme national</p>","STAT_CONC_DEF":"Cet indicateur mesure le taux de vaccination pour certaines maladies. L'Agence de la sant\u00e9 publique du Canada surveille la couverture vaccinale des enfants \u00e0 l'aide de l\u2019Enqu\u00eate nationale sur la couverture vaccinale des enfants.","DATA_COMP":"Data were readily available to report on this indicator as specified by the metadata. Please refer to the sources to access additional information on the metadata or source.","REC_USE_LIM":"Les vaccins pour enfants inclus dans l'ENCVE sont des vaccins financ\u00e9s par les fonds publics, dans le cadre des programmes de vaccination provinciaux et territoriaux. \n<br>\n<br>Les vaccins recommand\u00e9s seulement aux voyages et \u00e0 certains groupes \u00e0 haut risque ont \u00e9t\u00e9 exclus. \n<br>\n<br>L'enqu\u00eate a exclu les enfants habitant dans les r\u00e9serves des Premi\u00e8res Nations et en \u00e9tablissement.\n<br>\n<br>Les donn\u00e9es ventil\u00e9es par sexe ne sont disponibles qu'au niveau du Canada lors de la s\u00e9lection des cat\u00e9gories suivantes: \n\u00ab Vaccins recommand\u00e9s aux les enfants de 14 ans \u00bb, en particulier pour \u00ab H\u00e9patite B \u00bb ou \u00ab Virus du papillome humain (VPH) \u00bb.\n","PROGRESS_DETAILS":"   ","SDG_GOAL__GLOBAL":"<p>Objectif 3 : Permettre \u00e0 tous de vivre en bonne sant\u00e9 et promouvoir le bien-\u00eatre de tous \u00e0 tout \u00e2ge.</p>","SDG_TARGET__GLOBAL":"<p>Cible 3.b : Appuyer la recherche et le d\u00e9veloppement de vaccins et de m\u00e9dicaments contre les maladies, transmissibles ou non, qui touchent principalement les habitants des pays en\u00a0d\u00e9veloppement, donner acc\u00e8s, \u00e0 un co\u00fbt abordable, aux\u00a0m\u00e9dicaments et vaccins essentiels, conform\u00e9ment \u00e0 la\u00a0D\u00e9claration de Doha sur l\u2019Accord sur les aspects des droits de propri\u00e9t\u00e9 intellectuelle qui touchent au commerce (ADPIC) et la sant\u00e9 publique, qui r\u00e9affirme le droit qu\u2019ont les pays en d\u00e9veloppement de tirer pleinement parti des dispositions de cet accord qui m\u00e9nagent une flexibilit\u00e9 lorsqu\u2019il s\u2019agit de prot\u00e9ger la sant\u00e9 publique et, en particulier, d\u2019assurer l\u2019acc\u00e8s universel aux m\u00e9dicaments</p>","SDG_INDICATOR__GLOBAL":"<p>Indicateur 3.b.1 : Proportion de la population cible ayant re\u00e7u tous les vaccins pr\u00e9vus par le programme national</p>","source_active_1":true,"source_url_text_1":"Statistique Canada. Tableau 13-10-0870-01  Estimation de la couverture vaccinale pour les vaccins recommand\u00e9s chez les enfants et les femmes enceintes","source_url_1":"https://doi.org/10.25318/1310087001-fra","source_organisation_1":"Statistique Canada","source_periodicity_1":"Occasionnelle","source_geographical_coverage_1":"Canada, Province et territoire","reporting_status":"complete","un_designated_tier":"Niveau I","un_custodian_agency":"Organisation mondiale de la Sant\u00e9, Fonds des Nations Unies pour l'enfance (FISE)","goal_meta_link":"https://unstats.un.org/sdgs/metadata/files/Metadata-03-0b-01.pdf","goal_meta_link_text":"M\u00e9tadonn\u00e9es des objectifs de d\u00e9veloppement durable des Nations Unies"},"national_metadata_updated_date":"2025-08-21","national_data_updated_date":"2025-03-25","target_number":"3.b","goal_number":"3","indicator_sort_order":"03-0b-01"}